AzTrials
AzTrials

Chronic Obstructive Pulmonary Disease (COPD)LEAPNCT01998724

Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial

A study testing Tai Chi and Group Walking in people with Chronic Obstructive Pulmonary Disease (COPD), run by Beth Israel Deaconess Medical Center at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main purpose of this study is to determine the feasibility and effects of a 6-month tai chi exercise program as compared to a 6-month group walking program and standard care for patients with COPD that have recently completed a pulmonary rehabilitation program. Read more about this study

Who is it for?
Ages 40 years and older
What is being tested?
Tai Chi and Group Walking
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
2 sitesUnited States
Study dates
Aug 2012to Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • COPD defined as FEV1 (Forced expiratory volume in 1 second)/FVC (Forced vital capacity) <0.70 or chest CT evidence of emphysema
  • Age > 40 years
  • Any severity of COPD as defined by GOLD (Global Obstructive Lung Disease) stages 1, 2,3, or 4
  • Completion of standard pulmonary rehabilitation of at least 8 weeks duration within 24 weeks prior to study entry* *Defined as attending 65% of the program's sessions with a minimum of 10 sessions

Who cannot join

  • COPD exacerbation requiring steroids, antibiotics, ED visit or hospitalization within the past 2 weeks unless physician deems subject at baseline
  • Hypoxemia on walk test (O2 sat < 85% on oxygen)
  • Inability to ambulate due to vascular or other neuromuscular conditions that would preclude a walk test
  • Clinical signs of unstable cardiovascular disease (ie. chest pain on walk test)
  • Severe cognitive dysfunction (documented Mini-Mental Status Exam ≤ 24)
  • Non-English speaking
Show all 9Show fewer
  • Current regular practice of tai chi
  • Current diagnosis of lung cancer or treated for lung cancer within the past 5 years
  • Unstable/untreated mental health issue that precludes informed consent or otherwise affects ability to participate in the intervention

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • VA Healthcare System

    Boston, Massachusetts, 02130

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215

Other trials in United States

About this study

The main purpose of this study is to determine the feasibility and effects of a 6-month tai chi exercise program as compared to a 6-month group walking program and standard care for patients with COPD that have recently completed a pulmonary rehabilitation program.

Being tested
Tai Chi, Group Walking
Keywords
Chronic bronchitis, Emphysema, Pulmonary, COPD
Medical subject headings
Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic, Emphysema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tai ChiBehavioural

    24 week tai chi intervention designed for individuals with COPD

  • Group WalkingBehavioural

    24 week group walking intervention

Study groups in NCT01998724
Study groupRoleWhat they receive
Standard CareNo interventionNo intervention
Tai Chi ExerciseExperimental24 week Tai Chi intervention designed for individuals with COPD
Receives: Behavioral: Tai Chi
Group Walking ExerciseExperimental24 week group walking intervention
Receives: Behavioral: Group Walking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of tai chi intervention

    Willingness to participate, adherence, and safety

    Measured: 24 weeks

Secondary outcomes (6)
  1. Change from baseline - Disease specific quality of life

    Chronic Respiratory Questionnaire

    Measured: Baseline, 12 weeks, 24 weeks, 1 year

  2. Change from baseline - Exercise capacity

    Six minute walk distance

    Measured: Baseline, 12 weeks, 24 weeks

  3. Change from baseline - Dyspnea

    University of California, San Diego Shortness of Breath Questionnaire

    Measured: Baseline, 12 weeks, 24 weeks, 1 year

  4. Change from baseline - Psychosocial well-being

    Center for Epidemiologic Studies Depression Scale, Perceived Stress Scale, COPD Self-Efficacy Scale, Multidimensional Scale of Perceived Social Support

    Measured: Baseline, 12 weeks, 24 weeks, 1 year

  5. Changes from baseline - Pulmonary function

    Spirometry

    Measured: Baseline, 12 weeks, 24 weeks

  6. Change from baseline - Exercise Efficacy

    Daily exercise activities, step counts taken at baseline, 12 weeks, 24 weeks, 1 year

    Measured: Throughout study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2013 (estimated)
  2. Study startAug 2012
  3. Primary completionJan 2018
  4. Study completionSep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01998724
Sponsor's protocol ID
2012P000220
Other IDs
R01AT006358
Acronym
LEAP
Status last verified
Oct 2018
First submitted
25 Nov 2013
Last updated
3 Oct 2018
Results posted
No
Data monitoring committee
Yes

Publications

  • Gilliam EA, Kilgore KL, Liu Y, Bernier L, Criscitiello S, Litrownik D, Wayne PM, Moy ML, Yeh GY. Managing the experience of breathlessness with Tai Chi: A qualitative analysis from a randomized controlled trial in COPD. Respir Med. 2021 Aug;184:106463. doi: 10.1016/j.rmed.2021.106463. Epub 2021 May 15.

    PubMed 34023739
  • Moy ML, Wayne PM, Litrownik D, Beach D, Klings ES, Davis RB, Yeh GY. Long-term Exercise After Pulmonary Rehabilitation (LEAP): Design and rationale of a randomized controlled trial of Tai Chi. Contemp Clin Trials. 2015 Nov;45(Pt B):458-467. doi: 10.1016/j.cct.2015.09.004. Epub 2015 Sep 8.

    PubMed 26362690

Questions about this trial

What is this clinical trial studying?

A study testing Tai Chi and Group Walking in people with Chronic Obstructive Pulmonary Disease (COPD), run by Beth Israel Deaconess Medical Center at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of tai chi intervention (time frame: 24 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01998724, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in